Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients

Am J Gastroenterol. 2000 Feb;95(2):564-6. doi: 10.1111/j.1572-0241.2000.t01-1-01813.x.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amoxicillin / therapeutic use
  • Antacids / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Bismuth / therapeutic use
  • Chemoprevention
  • Colombia
  • Follow-Up Studies
  • Gastritis, Atrophic / drug therapy
  • Gastritis, Atrophic / microbiology*
  • Genotype
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / genetics*
  • Helicobacter pylori / pathogenicity
  • Humans
  • Metronidazole / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Penicillins / therapeutic use
  • Precancerous Conditions / prevention & control
  • Salicylates / therapeutic use
  • Stomach Neoplasms / prevention & control
  • Treatment Failure
  • Virulence

Substances

  • Antacids
  • Anti-Bacterial Agents
  • Organometallic Compounds
  • Penicillins
  • Salicylates
  • Metronidazole
  • bismuth subsalicylate
  • Amoxicillin
  • Bismuth